Skip to search.
 FTSE 100 Up 0.42%

Horizon Pharma plc (HZNP)

-NasdaqGS Ticker: QPVQZ6/ISIN: IE00BQPVQZ61
15.03 Down 4.36(22.49%) 8 Dec 21:00
Prev Close:19.39
Open:15.97
Bid:15.13 x 100
Ask:15.20 x 300
1y Target Est:30.33
Beta:1.13086
Next Earnings Date:N/A
Day's Range:15.00 - 16.18
52wk Range:13.05 - 23.44
Volume:29,461,732
Avg Vol (3m):3,473,210
Market Cap:2.42b
P/E (ttm):N/A
EPS (ttm):-0.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for HZNP at this time.

Comparison

Symbol% ChgMkt Cap
HZNPDown 22.49%2.42b
POZN 0.00%0.00
ABTUp 0.52%56.95b
PFEDown 0.80%187.76b

Key Statistics

Forward P/E (1 yr):6.01
P/S (ttm):3.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :2.01
Quarterly EPS Est (Dec-16) :0.50
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.56

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Horizon Pharma plc, a biopharmaceutical company, engages in identifying, developing, acquiring, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback